KFH - FONTANA
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2M
- Transactions
- 89
- Companies
- 16
- Average per transaction
- $22,038
Who reported the payments
| CSL Behring | $1,135,668 |
| Novartis | $287,942 |
| Jazz Pharmaceuticals Inc. | $138,750 |
| Centerline Biomedical Inc. | $117,360 |
| Vertex | $81,361 |
| Boehringer Ingelheim | $79,264 |
| Biotronik Inc. | $32,026 |
| Gynesonics, Inc. | $29,886 |
| Merck | $26,009 |
| Stryker | $17,227 |
| Bard Peripheral Vascular, Inc. | $8,100 |
| AbbVie | $4,700 |
| Incyte Corporation | $2,000 |
| Aesculap, Inc. | $782 |
| Zimmer Biomet | $260 |
| Olympus America Inc. | $37 |